ScienceDex / Researcher record
Suma Babu
FY2025 NIH rank #37
- Top 1% Funded
- Program Leader
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $36,529,039 | 3 | #51 |
| 2025 | $32,431,280 | 4 | #37 |
| 2026 | $24,064,952 | 2 | #124 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY2025 · selected4 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15262695Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2025 award records by amount
NIH award records listing Suma Babu as a PI. Multi-PI records show the full award amount for context.
- 3OT2NS136938-01S2OT2Co-investigatorAccess for All in ALS (ALL ALS) East Clinical Coordinating CenterMassachusetts General Hospital · Neurology (investigator's affiliation)$14.4Maward amount
- 5U01NS136021-03U01Co-investigatorAn Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with PridopidineMassachusetts General Hospital · Neurology (topic-inferred)$7.9Maward amount
- 5U01NS136020-03U01Co-investigatorIntermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMassachusetts General Hospital · Neurology (investigator's affiliation)$6.2Maward amount
- 3U01NS136020-03S1U01Co-investigatorIntermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMassachusetts General Hospital · Neurology (investigator's affiliation)$4Maward amount
Award organization
Organizations that administered FY2025 awards listing Suma Babu as a PI.
FY2025 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024$10M Cumulative Funding
- 2024$25M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #51
- 2024Entered Top 25% NationallyRanked #51
- 2024Entered Top 10% NationallyRanked #51
- 2024Entered Top 5% NationallyRanked #51
- 2024Entered Top 1% NationallyRanked #51
- 2025$50M Cumulative Funding
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Suma Babu.